Stock LYRA LYRA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Lyra Therapeutics, Inc.

Equities

LYRA

US55234L1052

Real-time Estimate Cboe BZX
Other stock markets
 02:51:23 2024-06-10 pm EDT 		5-day change 1st Jan Change
0.31 USD -3.25% Intraday chart for Lyra Therapeutics, Inc. -4.59% -94.08%
May. 21 Lyra Therapeutics Reduces Workforce to Extend Cash Runway MT
May. 21 Lyra Therapeutics, Inc. Announces Termination of John E. Bishop as Chief Technology Officer, Effective on or About June 20, 2024 CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Jefferies Downgrades Lyra Therapeutics to Hold, Price Target at $0.50
MT
HC Wainwright Downgrades Lyra Therapeutics to Neutral From Buy
MT
BTIG Assumes Lyra Therapeutics at Buy With $15 Price Target
MT
BofA Securities Increases Price Target on Lyra Therapeutics to $15 From $13, Maintains Buy Rating
MT
HC Wainwright Starts Lyra Therapeutics at Buy With $12 Price Target
MT
BTIG Adjusts Price Target on Lyra Therapeutics to $20 From $24, Maintains Buy Rating
MT
Cantor Fitzgerald Starts Lyra Therapeutics at Overweight With $15 Price Target
MT
LYRA THERAPEUTICS : BofA securities Adjusts Lyra Therapeutics PT to $26 From $19, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LYRA Stock
  4. News Lyra Therapeutics, Inc.
  5. Analyst Reco.